On the other hand, CPP-CAND, which integrated the positively charged HIV-TAT sequence, demonstrated senolytic activity (Figure
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A multicentre, randomised, double-blind, placebo-controlled study
However, a significant challenge in evaluating kidney outcomes lies in the inconsistent definitions of renal endpoints across studies, particularly regarding the thresholds for substantial eGFR decline, which vary from 30% to 57%
Q: Are there any alternatives to Semaglutide
Mimic fullness through food choices Semaglutide slows down gastric emptying, creating the sensation of being full for longer
Eur J Pharmacol 701: 203212